Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cytokine receptor common subunit gamma (IL-2RG, also known as common gamma chain or CD132) is a shared signaling subunit of type I cytokine receptors for IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. It forms heterodimeric or heterotrimeric receptor complexes with cytokine-specific subunits, associates with JAK1 and JAK3 kinases, and activates pathways including JAK-STAT, PI3K-Akt, and Ras-MAPK to regulate lymphocyte development, proliferation, differentiation, survival, and immune responses. Expressed on most lymphocytes, it is an integral membrane protein with extracellular, transmembrane, and intracellular domains, and its gene is on the X chromosome. Mutations lead to X-linked severe combined immunodeficiency (XSCID).
Blocks signaling of gamma c cytokines (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) by binding to IL-2RG
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytokine receptor common subunit gamma (IL-2RG) (CD132).